Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up

Ad

Trending Stock Alerts

AGRX Stock - Agile Therapeutics Stock Trading

home / stock / agrx

AGRX AGRX Quote AGRX Short AGRX News AGRX Articles AGRX Message Board

About | Agile Therapeutics Inc. (OTCMKTS:AGRX)

Agile Therapeutics Inc is a women's healthcare company to fulfill the unmet health needs of women. Its product candidates are designed to provide women with contraceptive options. The firm's initial product, Twirla, (levonorgestrel and ethinyl estradiol) transdermal system is a non-daily prescription contraceptive. Twirla is based on proprietary transdermal patch technology, called Skinfusion, which is designed to allow drug delivery through the skin.

Quote | Agile Therapeutics Inc. (OTCMKTS:AGRX)

Last:$1.51
Change Percent: 0.0%
Open:$1.51
Close:$1.51
High:$1.515
Low:$1.51
Volume:120,938
Last Trade Date Time:08/26/2024 03:00:00 am

News | Agile Therapeutics Inc. (OTCMKTS:AGRX)

  • Agile Therapeutics to be acquired by Spain-based Insud for an enterprise value of ~$45M

    2024-06-26 08:12:37 ET More on Agile Therapeutics Agile Therapeutics, Inc. (AGRX) Q4 2023 Earnings Call Transcript Financial information for Agile Therapeutics Read the full article on Seeking Alpha For further details see: Agile Therapeutics to be acquir...

    • June 26, 2024 08:12:37 am

    • |
    • SeekingAlpha
    • |
      • AGRX Stock
      • AGRX Quote
      • AGRX Short
      • AGRX News
      • AGRX Articles
      • AGRX Message Board
  • Agile Therapeutics Non-GAAP EPS of -$0.63, revenue of $5.7M

    2024-05-15 16:58:52 ET More on Agile Therapeutics Agile Therapeutics, Inc. (AGRX) Q4 2023 Earnings Call Transcript Agile Therapeutics Q4 2023 Earnings Preview Agile Therapeutics announces delisting from Nasdaq Financial information for Agile Therapeutics ...

    • May 15, 2024 04:58:52 pm

    • |
    • SeekingAlpha
    • |
      • AGRX Stock
      • AGRX Quote
      • AGRX Short
      • AGRX News
      • AGRX Articles
      • AGRX Message Board

Message Board Posts | Agile Therapeutics Inc. (OTCMKTS:AGRX)

Subject By Source When
whytestocks: $AGRX News Article - Corium Pharma Solutions Names Ernie De Paolantonio as Chief Financ whytestocks investorshangout 02/15/2023 4:55:45 PM
Premarket craziness today :) PyroStocks investorshub 02/02/2023 7:30:03 PM
Bounce coming PyroStocks investorshub 02/01/2023 12:17:03 AM
Louis Rossman with 122k subscribers on YouTube that PyroStocks investorshub 01/29/2023 2:30:21 PM
znewcar1: $AGRX 23% v2,3M c.2849 f40,614M H.289 ml.175 YL.21 znewcar1 investorshangout 01/06/2023 5:45:34 AM
Stock Information
Get AGRX Alerts

News, Short Squeeze, Breakout and More Instantly...

Agile Therapeutics Inc. Company Name:

AGRX Stock Symbol:

OTCMKTS Market:

Agile Therapeutics Inc. Website:

Agile Therapeutics Inc. Logo

Ad

Trending Stock Alerts
RECENT AGRX NEWS
  • AGRX - Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

    First Quarter Net Revenue Increased 58% and Factory Sales Increased 3% from Fourth Quarter 2023 Twirla First Quarter 2024 Demand Rebounded 18% from Fourth Quarter 2023 PRINCETON, N.J., May 15, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Pink: AGRX), a women's healthcare com...

  • AGRX - Expected US Company Earnings on Thursday, May 9th, 2024

    AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...

  • AGRX - Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update

    Full Year 2023 Net Revenue Increased 80% from 2022 While OPEX Decreased 33% Twirla Demand and Factory Sales Up 121% and 114% Respectively in 2023 vs 2022 Company Completes Pay-Off of Debt Facility in First Quarter 2024 Twirla Demand Expected to Rebound in First Quarter 2...

  •
  • Research
  • Stock Search
  • News Releases
  • Articles
  • Topics
  • Message Boards
  • Trending Stocks
  • Trending Feed
  • Trending Alerts
  • Watchlist
  • Short Information
  • Stock Wall
  • Link Twitter
  • Sign Up
  • Login
  • Contact

Link your Twitter Account

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.

Trending Stock Alerts

Trending Stock Alerts

Our Next Stock Alert could be Coming in Minutes!

Sign Up Today To Get Full Access To Our Next Stock Report!

  • Day Before Email and Text Notifications of New Alerts
  • Day of Email and Text Notifications
  • Trending Stocks, Watchlist and News Releases
  • Mobile App Notifications
Trending Stock Alerts

Get AGRX Alerts

Get AGRX Alerts

News, Short Squeeze, Breakout and More Instantly...

Sign up or login to continue

Sign up or login to continue.

Forgot password?


Mobile Number Subscribers

Market Wire News provides notifications to customers about updates, service, reminders, or products. Current and new customers of Market Wire News will enter their mobile numbers on a web opt-in form https://marketwirenews.com. Supported Carriers are as follows Alltel, AT&T, Cincinnati Bell, Dobson Cellular Systems, Inter Op, MetroPCS®, Nextel Communications, Sprint PCS, T-Mobile®, U.S. Cellular®, Verizon Wireless, and Virgin Mobile U.S. T-Mobile® is not liable for delayed or undelivered messages. There are no premium charges for joining Market Wire News service. Message and data rates may apply. Subscribers to Market Wire News service may receive up to 500 per month.

How to Opt Out

To opt-out of the Market Wire News program, send or text STOP, END, QUIT, CANCEL or UNSUBSCRIBE to (844) 931-3999. An unsubscribe message will be sent to your number confirming the cancellation, but no more messages will be sent after that one.

Mobile Support

For support or information about a Market Wire News, send or text HELP to (844) 931-3999. Optionally, you may email support@marketwirenews.com.

Disclaimer

This electronic content is for the purposes of solicitation subscriptions for Market Wire News. Market Wire News expects to generate new advertisement revenue resulting from the distribution of this electronic content. The amount of which is unknown at this time. Market Wire News is not a registered investment adviser or broker-dealer. This electronic content does not provide a professional analysis of a any stock financial position. any stock's financial position and all other information regarding the featured Company should be verified directly with any stock. This electronic content is provided as an information service only, and any statements and opinions in this electronic content should not be construed as an offer or solicitation to buy or sell any security. Market Wire News accepts no liability for any loss arising from an investor's reliance on or use of this electronic content. An investment in any company is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Market Wire News does not own, buy, sell or plans to own, buy, sell, and of any stock's shares. This electronic content contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Please read our full disclaimer for compensation and more detailed information.

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Log In

Sign Up

Stay Connected

| X

| Facebook

| BlueSky

| LinkedIn

| Telegram

| Discord

Contact

Privacy

Terms of Service

Disclaimer

© 2024 Market Wire News 1